-
The marketing application of Shandong New Era Metformin Hydrochloride Sustained-Release Tablets was approved
Time of Update: 2022-05-20
On April 15, NMPA released the latest drug approval information, and Shandong New Era Pharmaceuticals' metformin hydrochloride sustained-release tablet category 4 generic
-
The market of 600 million ushered in the approval of the new dosage form of Heyi Pharmaceutical's lidocaine hydrochloride ophthalmic gel
Time of Update: 2022-04-20
> At present, lidocaine hydrochloride dosage forms include injections, gels, patches and aerosols, among which the market share of injections is close to 80%. There are more than 30
-
New Era Pharmaceuticals Fasudil Hydrochloride Injection Passes Consistency Evaluation
Time of Update: 2022-03-08
Review of Fasudil Injection Source: Minet Consistency Evaluation Database Including Shandong New Times, there are currently 8 companies whose fasudil hydrochloride injection has passed the consistency evaluation, and the product has been included in the fifth batch of centralized procurement.
-
Luye Pharma's new antidepressant drug Ansufaxine Hydrochloride Sustained-Release Tablets Phase II Clinical Data Released
Time of Update: 2022-01-10
), norepinephrine (NE) and dopamine (DA). Completed Phase I to Phase III clinical trials in China and is in the stage of market application . >The phase II clinical trial data released
-
Saisheng Pharmaceutical declares for listing of new antibiotic Tilavacin Hydrochloride for injection
Time of Update: 2021-10-21
According to the prospectus of Saisheng Pharmaceutical, the market size of anti-MRSA antibacterial drugs in China in 2019 is RMB 4.
-
Luye Pharma’s new antidepressant drug Ansufaxine Hydrochloride Sustained-Release Tablets was accepted by CDE
Time of Update: 2021-06-16
On June 10th, Luye Pharmaceutical Group announced that its self-developed Chinese chemical drug Class 1 new drug Ansufacine Hydrochloride Sustained-Release Tablets (LY03005) has been officially accepted by the Drug Evaluation Center of the China National Medical Products Administration .
-
Luye Pharma's Class 1 new drug Ansufaxine Hydrochloride Sustained-Release Tablets reached the preset end point in Phase III clinical trials
Time of Update: 2021-04-27
The China Phase III clinical trial of LY03005 is a multi-center, randomized, double-blind, placebo-controlled study to verify the effectiveness and safety of LY03005 in the treatment of depression.
-
Announcement on the approval of L-amateline hydrochloride as a new variety of food additives and the expanded use of 3 food additives
Time of Update: 2020-06-30
in accordance with the Provisions of the Food Safety Law of the People's Republic of China and the Measures for the Administration of New Varieties of Food Additives, and approved, L-amateag glycine hydrochloride as a new variety of food
-
Pro Pharma's new drug, antatory hydrochloride, gets FDA approval
Time of Update: 2020-06-08
the main manufacturers of amphetamine-release tablets in the United States are PAR, TEVA, etc., and there is currently no product spree of the dosage form ( marketed.
-
The project of "industrialization of new anesthetic drugs hydromorphone hydrochloride
Time of Update: 2020-04-03
On March 31, 2014, the company received 16 million yuan of relevant state subsidies.
-
Enhua pharmaceutical heavy new drug Remifentanil Hydrochloride for Injection approval completed
Time of Update: 2020-04-03
According to the information on the website of CFDA on October 13, the review status of remifentanil hydrochloride for injection, a heavy new drug of Enhua Pharmaceutical Co., Ltd., was changed to "approved - to be certified".
-
The production of "loratrak hydrochloride", a new anti-tumor drug of Kangchen Pharmaceutical Co., Ltd., has been declared
Time of Update: 2020-04-03
Loratrek hydrochloride for injection, a national first-class anti-cancer drug developed by Kangchen Pharmaceutical Development Co., Ltd., is a non classical structure of folic acid
-
The second domestic new hepatitis C drug clopevir hydrochloride capsule was approved for marketing
Time of Update: 2020-02-12
Recently, the State Drug Administration approved the listing of clopevir hydrochloride capsule (trade name: kailivi) (Code: kw-136), a class 1 innovative drug of Beijing
-
Priority review of the 4th new indication of Zhengda Tianqing androtinib hydrochloride capsule
Time of Update: 2020-01-19
Wen Jie winter On January 17, CDE announced a new batch of applications to be included in the priority review and approval list, including the listing application for the fourth new indication of Zhengda Tianqing androtinib hydrochloride capsule.
-
Huahai Pharmaceutical Co., Ltd.: new specification supplement application of doxycycline
Time of Update: 2019-06-20
On June 19, Huahai pharmaceutical announced that the company's supplementary application for the new specifications of doxycycline hydrochloride sustained-release tablets declared
-
Ensatinib hydrochloride, a new drug of Beida pharmaceutical, was included in the priority review procedure by the State Food and Drug Administration
Time of Update: 2019-02-25
Beida pharmaceutical has just released a notice that its new drug, ensatinib hydrochloride, was included in the publicity list of the proposed priority review varieties by the drug review center of the National Drug Administration (nmpa) on February 15, 2019.
-
New specification supplement application of doxycycline hydrochloride sustained release tablets of Huahai Pharmaceutical Co., Ltd. approved by FDA
Time of Update: 2019-02-22
The original drug of doxycycline hydrochloride sustained-release tablets was developed by mayneparma company, and was approved to be listed in the United States as early as 2008.
-
Shanghai Pharmaceutical Institute's "national class 1.1 new drug Antofloxacin hydrochloride
Time of Update: 2018-01-09
Source: Dream pursuing tour January 8, 2018, 2017 National Science and technology award conference was held in Beijing
Led by Yang Yushe, researcher of Shanghai
-
Materials and tablets of cytarabine hydrochloride valine ester, a new chemical drug of Shenyang Pharmaceutical University, obtained clinical approval
Time of Update: 2017-01-07
Recently, the raw materials and tablets (acceptance No.: cxhl1502498, cxhl1502499 and cxhl1502500) of the new chemical drug cytarabine hydrochloride valine ester, developed by Shenyang Pharmaceutical University, have obtained the approval documents for clinical trials.
-
Hydroxypiperone hydrochloride, a class 1.1 new drug of Huahai pharmaceutical, has obtained
Time of Update: 2015-08-06
The company announced that 1.1 new antidepressant mepyridone hydrochloride was approved for clinical trial, which is another important progress made in the process of industrial upgrading, adding impetus to the medium and long-term development of the company.
